Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study

Oncel I., SANCAR M., KONUŞKAN B., Arioz F., TEZCAN S., ARMAN KANDIRMAZ E., ...Daha Fazla

PEDIATRIC NEUROLOGY, cilt.110, ss.59-63, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 110
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.pediatrneurol.2020.05.009
  • Dergi Adı: PEDIATRIC NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.59-63
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Aprepitant is a neurokinin-1 receptor antagonist approved for the treatment of chemotherapy-induced nausea. We aimed to investigate the safety and efficacy of aprepitant in patients with subacute sclerosing panencephalitis.